SCINO PHARM

Business Nature: Manufacturer

Company Profile:

ScinoPharm Taiwan, Ltd. is a leading global provider of Active Pharmaceutical Ingredients (APIs) and integrated contract development and manufacturing services. Established in 1997, the company specializes in the development and production of high-quality APIs, including complex oncology drugs, peptides, and specialized small molecules. ScinoPharm operates state-of-the-art manufacturing facilities that comply with international regulatory standards, such as the US FDA, EMA, and TFDA. The company serves as a strategic partner to global pharmaceutical companies, offering comprehensive solutions ranging from process research and development to commercial-scale manufacturing. With a strong focus on innovation, quality assurance, and regulatory excellence, ScinoPharm plays a critical role in the global pharmaceutical supply chain.

Company: ScinoPharm Taiwan Ltd.

Products Manufactured or Sold:

Docetaxel

Irinotecan

Oxaliplatin

Pemetrexed

Gemcitabine

Bortezomib

Cabazitaxel

Bendamustine Hydrochloride

Dabigatran Etexilate Mesylate

Rivaroxaban

Apixaban

Voriconazole

Posaconazole

Fulvestrant

Leuprolide Acetate

Goserelin Acetate

Triptorelin Acetate

Degarelix